Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Grymonprez (Ghent, Belgium), V. Vakaet (Ghent, Belgium), M. Kavousi (Rotterdam, Netherlands), B. Stricker (Rotterdam, Netherlands), M. Ikram (Rotterdam, Netherlands), J. Heeringa (Rotterdam, Netherlands), O. Franco (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), L. Lahousse (Ghent, Belgium). The role of interleukin 6 on incident atrial fibrillation in COPD patients. 3612

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for asymptomatic atrial fibrillation in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Atrial flutter and fibrillation in patients with chronic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 OSA and atrial fibrillation Source: Sleep and Breathing Conference 2021 Year: 2021 Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation Source: Eur Respir J 2007; 30: Suppl. 51, 707s Year: 2007 Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018 Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 1343-1348 Year: 2011 Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: The independent role of sleep disordered breathing Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 Atrial fibrillation in critical care patients with respiratory failure: Incidence and clinical effects Source: Annual Congress 2012 - Multidisciplinary critical care Year: 2012 Risk factors for new-onset atrial fibrillation in patients with asthma-COPD overlap syndrome (ACOS) Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Paroxysmal atrial fibrillation as a symptom of pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Reduced lung function and risk of atrial fibrillation in a prospective cohort study Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002 Atrial fibrillation and stroke risk in relation to COPD and chronic productive cough Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Is COPD a risk factor for electrocardiographic abnormalities and cardiac arrhythmias? Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Possible mechanisms of ventricular arrhythmias in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005